Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yemin Wang

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Cell Reports|April 6, 2017
DGCR8 Mediates Repair of UV-Induced DNA Damage Independently of RNA ProcessingPhilamer C Calses, Kiranjit K Dhillon, Nyka Tucker, et al.
The American Journal of Surgical Pathology|April 16, 2019
DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell TumorsAnthony N Karnezis, Yemin Wang, Jacqueline Keul, et al.
Genes and Immunity|April 28, 2026
Immunological and prognostic impact of NRF2 in high grade serous ovarian cancerSamera H Hamad, Chelsea Katz, Helen Toma, et al.
Gynecologic Oncology|December 17, 2020
Re-assigning the histologic identities of COV434 and TOV-112D ovarian cancer cell linesAnthony N Karnezis, Shary Yuting Chen, Christine Chow, et al.
The Journal of Pathology|June 3, 2015
Recurrent DICER1 hotspot mutations in endometrial tumours and their impact on microRNA biogenesisJiamin Chen, Yemin Wang, Melissa K McMonechy, et al.
Cancers|September 14, 2024
Genome-Wide CRISPR Screen Identifies KEAP1 Perturbation as a Vulnerability of ARID1A-Deficient CellsLouis-Alexandre Fournier, Forouh Kalantari, James P Wells, et al.
Histopathology|January 15, 2025
Prognostic values of molecular subtypes and SWI/SNF protein expression in de-differentiated/undifferentiated endometrial carcinomaChae Young Shin, Bengul Gokbayrak, Valerie L Tao, et al.
The Journal of Pathology|April 27, 2017
The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic typeYemin Wang, Shary Yuting Chen, Anthony N Karnezis, et al.
BMC Cancer|February 25, 2014
A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylationKimberly C Wiegand, Bryan T Hennessy, Samuel Leung, et al.
NPJ Precision Oncology|July 24, 2025
Molecular subtyping of endometrial carcinoma cell lines uncovers subtype-specific targetable vulnerabilitiesEunice S Li, Rebecca Ho, Ran Tao, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Cell Reports|April 6, 2017
DGCR8 Mediates Repair of UV-Induced DNA Damage Independently of RNA ProcessingPhilamer C Calses, Kiranjit K Dhillon, Nyka Tucker, et al.
The American Journal of Surgical Pathology|April 16, 2019
DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell TumorsAnthony N Karnezis, Yemin Wang, Jacqueline Keul, et al.
Genes and Immunity|April 28, 2026
Immunological and prognostic impact of NRF2 in high grade serous ovarian cancerSamera H Hamad, Chelsea Katz, Helen Toma, et al.
Gynecologic Oncology|December 17, 2020
Re-assigning the histologic identities of COV434 and TOV-112D ovarian cancer cell linesAnthony N Karnezis, Shary Yuting Chen, Christine Chow, et al.
The Journal of Pathology|June 3, 2015
Recurrent DICER1 hotspot mutations in endometrial tumours and their impact on microRNA biogenesisJiamin Chen, Yemin Wang, Melissa K McMonechy, et al.
Cancers|September 14, 2024
Genome-Wide CRISPR Screen Identifies KEAP1 Perturbation as a Vulnerability of ARID1A-Deficient CellsLouis-Alexandre Fournier, Forouh Kalantari, James P Wells, et al.
Histopathology|January 15, 2025
Prognostic values of molecular subtypes and SWI/SNF protein expression in de-differentiated/undifferentiated endometrial carcinomaChae Young Shin, Bengul Gokbayrak, Valerie L Tao, et al.
The Journal of Pathology|April 27, 2017
The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic typeYemin Wang, Shary Yuting Chen, Anthony N Karnezis, et al.
BMC Cancer|February 25, 2014
A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylationKimberly C Wiegand, Bryan T Hennessy, Samuel Leung, et al.
NPJ Precision Oncology|July 24, 2025
Molecular subtyping of endometrial carcinoma cell lines uncovers subtype-specific targetable vulnerabilitiesEunice S Li, Rebecca Ho, Ran Tao, et al.
Pageof 9